Thomas browne8 Jan 2018 15:16
I believe that the wise investors are beginning to realise that this investment is potentially going to be the share of 2018 and the SP rise confirms what I envisaged happening on a daily basis through to March, however at double digit rises occasionally. Any R and D business hasa massive re rating whendeals happen and royalties come in and commercialisation of the different products starts to happen.This is what we have here and it is far superior to the products currently available. This will even see the long-term holders invested at 80p or more multibag .So in my opinion anyone investing below 80p will be doing very well. It is the aligning of everything that this company has been striving for with all it's different meds and will lead to a significant re rate and once royalties come in the SP growth will be expotential. However a deal maybe announced to take this lockstockand barrel in the first half of this year as another poster has suggested and I could not envisage less than two pound. FUM's year is 2018 here and now.